Good news about the treatment of Alzheimer’s disease is hard to find. However, new breakthrough research is hailed as the “best news” in dementia research for 25 years and a potential “game changer” for people with the disease. In a preliminary trial a bioengineered medication called aducanumab has demonstrated the ability to clear accumulations of beta-amyloid proteins—a hallmark of Alzheimer’s—from the brain. Compared with subjects receiving a placebo medication, those who got monthly infusions of aducanumab in high doses appeared to experience less progressive loss in mental function.
Experimental drug slows memory loss and halts Alzheimer’s decline
More of Today's Solutions
Understanding The Neurodivergent Perspective
What’s it like to live in a body and brain that functions differently than the majority of your peers? We are not talking about ...
Read MoreGiant tortoise believed extinct for 100 years is actually alive
We previously shared a story about a family finding their pet tortoise alive and well in their attic after it had been missing for ...
Read MoreAI could identify chickens in distress and improve conditions
We’ve already written before about AI’s potential to improve pigs’ lives by listening to them. Now, scientists have found they can use AI on ...
Read MoreThe future of healing: 3D printing skin directly onto open wounds
Pennsylvania State University researchers achieved a major medical science breakthrough by being the first team ever to 3D print real human skin tissue directly ...
Read More
